BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18469873)

  • 1. Selection of cord blood unit(s) for transplantation.
    Wall DA; Chan KW
    Bone Marrow Transplant; 2008 Jul; 42(1):1-7. PubMed ID: 18469873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sibling donor cord blood banking for children with sickle cell disease.
    Reed W; Walters M; Trachtenberg E; Smith R; Lubin BH
    Pediatr Pathol Mol Med; 2001; 20(2):167-74. PubMed ID: 12673840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cord blood banking: 'providing cord blood banking for a nation'.
    Querol S; Rubinstein P; Marsh SG; Goldman J; Madrigal JA
    Br J Haematol; 2009 Oct; 147(2):227-35. PubMed ID: 19796272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of the clinical use of umbilical cord blood hematopoietic cells.
    Gluckman E; Rocha V
    Cytotherapy; 2005; 7(3):219-27. PubMed ID: 16081348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities.
    Dumont-Lagacé M; Feghaly A; Meunier MC; Finney M; Van't Hof W; Masson Frenet E; Sauvageau G; Cohen S
    Transplant Cell Ther; 2022 Jul; 28(7):410.e1-410.e5. PubMed ID: 35311667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use of cord blood for stem cell transplantation.
    Vanichsetakul P
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S93-100. PubMed ID: 17718293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
    Gonzalo-Daganzo R; Regidor C; Martín-Donaire T; Rico MA; Bautista G; Krsnik I; Forés R; Ojeda E; Sanjuán I; García-Marco JA; Navarro B; Gil S; Sánchez R; Panadero N; Gutiérrez Y; García-Berciano M; Pérez N; Millán I; Cabrera R; Fernández MN
    Cytotherapy; 2009; 11(3):278-88. PubMed ID: 19308773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing unrelated donor cord blood transplantation.
    Barker JN; Rocha V; Scaradavou A
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):154-61. PubMed ID: 19147098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cord blood: from bench to bedside].
    Bron D; De Bruyn C; Balasse H; Ley P; De Hemptinne D; von Lennep E; Homans C; Marckowicz E; Mathieu P; Deleuse MD; Francotte J; Thomas D; Dorval C; Dejeneffe M; Andrien M; Delforge A
    Bull Cancer; 2008 Mar; 95(3):314-9. PubMed ID: 18390411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplant of bone marrow and cord blood hematopoietic stem cells in pediatric practice, revisited according to the fundamental principles of bioethics.
    Burgio GR; Locatelli F
    Bone Marrow Transplant; 1997 Jun; 19(12):1163-8. PubMed ID: 9208108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European survey on clinical use of cord blood for hematopoietic and non-hematopoietic indications.
    Gratwohl A; Baldomero H
    Transfus Apher Sci; 2010 Jun; 42(3):265-75. PubMed ID: 20427240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term cryostorage of UC blood units: ability of the integral segment to confirm both identity and hematopoietic potential.
    Goodwin HS; Grunzinger LM; Regan DM; McCormick KA; Johnson CE; Oliver DA; Mueckl KA; Alonso JM; Wall DA
    Cytotherapy; 2003; 5(1):80-6. PubMed ID: 12745582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34(+) progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation.
    Lemarie C; Esterni B; Calmels B; Dazey B; Lapierre V; Lecchi L; Meyer A; Rea D; Thuret I; Chambost H; Curtillet C; Chabannon C; Michel G
    Bone Marrow Transplant; 2007 Apr; 39(8):453-60. PubMed ID: 17334384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NETCORD: a cord blood allocation network.
    Hakenberg P; Kögler G; Wernet P
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S17-8. PubMed ID: 9715876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome.
    Boelens JJ; Rocha V; Aldenhoven M; Wynn R; O'Meara A; Michel G; Ionescu I; Parikh S; Prasad VK; Szabolcs P; Escolar M; Gluckman E; Cavazzana-Calvo M; Kurtzberg J;
    Biol Blood Marrow Transplant; 2009 May; 15(5):618-25. PubMed ID: 19361754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks.
    Wagner E; Duval M; Dalle JH; Morin H; Bizier S; Champagne J; Champagne MA
    Transfusion; 2006 Jul; 46(7):1190-8. PubMed ID: 16836567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why cord blood?
    Rubinstein P
    Hum Immunol; 2006 Jun; 67(6):398-404. PubMed ID: 16728260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental basis of cord blood transplantation.
    Broxmeyer HE; Cooper S; Hass DM; Hathaway JK; Stehman FB; Hangoc G
    Bone Marrow Transplant; 2009 Nov; 44(10):627-33. PubMed ID: 19802026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Search for unrelated donor umbilical cord blood units for allogeneic stem cell transplantation: results in two time periods.
    Barriga F; Wietstruck MA
    Transplant Proc; 2007 Apr; 39(3):629-30. PubMed ID: 17445562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Umbilical cord blood transplantation: pros, cons and beyond.
    Stanevsky A; Goldstein G; Nagler A
    Blood Rev; 2009 Sep; 23(5):199-204. PubMed ID: 19282073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.